Chinese Pharmaceuticals & Biotech Undervalued Small Caps

KPC PharmaceuticalsInc

Market Cap: CN¥9.0b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.1b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥10.4b

Engages in the blood product businesses in China.

Wuhan Keqian BiologyLtd

Market Cap: CN¥7.4b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

Amoy Diagnostics

Market Cap: CN¥7.6b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

AcrobiosystemsLtd

Market Cap: CN¥7.3b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥8.4b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Wuhan Hvsen BiotechnologyLtd

Market Cap: CN¥5.1b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥10.3b

A biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.